Trials / Completed
CompletedNCT01362933
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients
National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 502 (actual)
- Sponsor
- Floralis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of venous thromboembolism in cancer patients is specific and has been validated in trials that favor the use of LMWH (Low Molecular Weight Heparin) instead of VKA (Vitamin K Antagonist) treatment during 6 months. International recommendations have diffused this option.It is necessary to evaluate the compliance of physicians to this treatment by measuring the number of patients with cancer treated with long term use of LMWH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VTE treatment in cancer patient description | proportion of patients treated for evolutive VTE according to international recommendations |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-01-01
- Completion
- 2012-07-01
- First posted
- 2011-06-01
- Last updated
- 2015-03-06
Locations
49 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01362933. Inclusion in this directory is not an endorsement.